Characterization of non-conventional opioid binding sites in rat and human lung.
Indirect evidence suggests that nebulized morphine relieves dyspnoea and bronchoconstriction via opioid receptors within the lung. This study used equilibrium binding studies to characterize opioid binding sites in lung membrane preparations. [3H]Morphine and [3H]naloxone were incubated separately with homogenates of Wistar rat brain and lung, and human lung. Binding affinities for both morphine and naloxone in rat and human lung were two orders of magnitude lower than those in brain. However, opioid binding site densities in lung were up to 100 times greater than that in brain. The addition of Na+ or GTP to lung homogenate preparations caused atypical effects on opioid binding. Na+ (50 mM) decreased the specific binding of [3H]naloxone 50% viz-à-vis a 20% increase in binding in the brain. GTP (100 microM) caused a 200% increase in the apparent capacity of morphine binding in the lung compared with a marked decrease in binding in the brain.
Department of Pharmacy, University of Queensland, Brisbane, Australia.
P J
PJ
Cabot
P R
PR
Dodd
T
T
Cramond
M T
MT
Smith
D000818:Animals; D001665:Binding Sites; D006160:Guanosine Triphosphate / Q000494:pharmacology; D006801:Humans; D008168:Lung / Q000378:metabolism*; D008297:Male; D009020:Morphine / Q000378:metabolism*; D009270:Naloxone / Q000378:metabolism*; D051381:Rats; D017208:Rats, Wistar; D012964:Sodium / Q000494:pharmacology
D009270:Naloxone; D009020:Morphine; D006160:Guanosine Triphosphate; D012964:Sodium